{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:10:18Z","timestamp":1783008618486,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fundamental Research Program of Shanxi Province","award":["202403021222387"],"award-info":[{"award-number":["202403021222387"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03653-1","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:23:45Z","timestamp":1759173825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Low-dose rituximab in lupus enteritis: a comparative study on its efficacy in modulating mucosal immunity and reducing inflammation"],"prefix":"10.1186","volume":"27","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuJie","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiangYu","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"1","key":"3653_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.rdc.2017.09.011","volume":"44","author":"BN Brewer","year":"2018","unstructured":"Brewer BN, Kamen DL. Gastrointestinal and hepatic disease in systemic lupus erythematosus. Rheum Dis Clin North Am. 2018;44(1):165\u201375.","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"3653_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/jgh.16373","volume":"39","author":"S Matsuyama","year":"2024","unstructured":"Matsuyama S, Fukuda A, Ohana M, Gastrointestinal. Lupus enteritis with duodenojejunal fistula causing intestinal obstruction and Gastrointestinal perforation. J Gastroenterol Hepatol. 2024;39(2):220\u20131.","journal-title":"J Gastroenterol Hepatol"},{"key":"3653_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1750-1172-8-67","volume":"8","author":"P Janssens","year":"2013","unstructured":"Janssens P, Arnaud L, Galicier L, Mathian A, Hie M, Sene D, et al. Lupus enteritis: from clinical findings to therapeutic management. Orphanet J Rare Dis. 2013;8:67.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"3653_CR4","doi-asserted-by":"publisher","first-page":"102777","DOI":"10.1016\/j.autrev.2021.102777","volume":"20","author":"M Zouali","year":"2021","unstructured":"Zouali M. B lymphocytes, the Gastrointestinal tract and autoimmunity. Autoimmun Rev. 2021;20(4):102777.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"3653_CR5","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1177\/0961203320910803","volume":"29","author":"G Kenar","year":"2020","unstructured":"Kenar G, Atay K, Yuksek GE, Oz B, Koca SS. Gastrointestinal vasculitis due to systemic lupus erythematosus treated with rituximab: a case report. Lupus. 2020;29(6):640\u20133.","journal-title":"Lupus"},{"issue":"1","key":"3653_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.31138\/mjr.080624.rar","volume":"35","author":"AH Hussein","year":"2024","unstructured":"Hussein AH, Altamimi BL. Rapid and remarkable response to rituximab in a case of lupus enteritis: challenging the norm. Mediterr J Rheumatol. 2024;35(1):187\u201391.","journal-title":"Mediterr J Rheumatol"},{"issue":"2","key":"3653_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/0961203309345787","volume":"19","author":"JS Oh","year":"2010","unstructured":"Oh JS, Kim YG, Lee SG, Lee CK, Yoo B. Successful treatment of recurrent lupus enteritis with rituximab. Lupus. 2010;19(2):220\u20132.","journal-title":"Lupus"},{"issue":"2","key":"3653_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.5152\/eurjrheum.2018.17096","volume":"5","author":"F Alshaiki","year":"2018","unstructured":"Alshaiki F, Obaid E, Almuallim A, Taha R, El-Haddad H, Almoallim H. Outcomes of rituximab therapy in refractory lupus: A meta-analysis. Eur J Rheumatol. 2018;5(2):118\u201326.","journal-title":"Eur J Rheumatol"},{"issue":"5","key":"3653_CR9","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/rheumatology\/kead328","volume":"63","author":"LD Veeken","year":"2024","unstructured":"Veeken LD, Opdam MAA, Verhoef LM, Popa C, van Crevel R, den Broeder AA. Infection incidence, timing and dose dependency in rheumatoid arthritis patients treated with rituximab: a retrospective cohort study. Rheumatology (Oxford). 2024;63(5):1246\u201350.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"3653_CR10","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/rheumatology\/ker176","volume":"50","author":"H Chen","year":"2011","unstructured":"Chen H, Zheng W, Su J, Xu D, Wang Q, Leng X, et al. Low-dose rituximab therapy for refractory thrombocytopenia in patients with systemic lupus erythematosus\u2013a prospective pilot study. Rheumatology (Oxford). 2011;50(9):1640\u20134.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"3653_CR11","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European league against rheumatism\/american college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400\u201312.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"3653_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.semarthrit.2013.11.005","volume":"43","author":"S Yuan","year":"2014","unstructured":"Yuan S, Ye Y, Chen D, Qiu Q, Zhan Z, Lian F, et al. Lupus mesenteric vasculitis: clinical features and associated factors for the recurrence and prognosis of disease. Semin Arthritis Rheum. 2014;43(6):759\u201366.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"3653_CR13","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1177\/0961203310374337","volume":"19","author":"HH Chng","year":"2010","unstructured":"Chng HH, Tan BE, Teh CL, Lian TY. Major Gastrointestinal manifestations in lupus patients in asia: lupus enteritis, intestinal pseudo-obstruction, and protein-losing gastroenteropathy. Lupus. 2010;19(12):1404\u201313.","journal-title":"Lupus"},{"issue":"7","key":"3653_CR14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","volume":"44","author":"DA Isenberg","year":"2005","unstructured":"Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles lupus assessment group\u2019s disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005;44(7):902\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3653_CR15","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288\u201391.","journal-title":"J Rheumatol"},{"issue":"4","key":"3653_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0002-9343(82)90331-X","volume":"73","author":"TM Zizic","year":"1982","unstructured":"Zizic TM, Classen JN, Stevens MB. Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am J Med. 1982;73(4):525\u201331.","journal-title":"Am J Med"},{"issue":"2","key":"3653_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0002-9343(97)80020-4","volume":"103","author":"F Medina","year":"1997","unstructured":"Medina F, Ayala A, Jara LJ, Becerra M, Miranda JM, Fraga A. Acute abdomen in systemic lupus erythematosus: the importance of early laparotomy. Am J Med. 1997;103(2):100\u20135.","journal-title":"Am J Med"},{"issue":"5","key":"3653_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1191\/0961203304lu1023oa","volume":"13","author":"E Tackey","year":"2004","unstructured":"Tackey E, Lipsky PE, Illei GG. Rationale for interleukin-6 Blockade in systemic lupus erythematosus. Lupus. 2004;13(5):339\u201343.","journal-title":"Lupus"},{"issue":"2","key":"3653_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cyto.2010.02.017","volume":"50","author":"R Zhang","year":"2010","unstructured":"Zhang R, Xing M, Ji X, Gu L, Yang X, Wang H, et al. Interferon-alpha and interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34\u2009+\u2009hematopoietic precursor cells. Cytokine. 2010;50(2):195\u2013203.","journal-title":"Cytokine"},{"key":"3653_CR20","doi-asserted-by":"publisher","first-page":"e1801","DOI":"10.6061\/clinics\/2020\/e1801","volume":"75","author":"J Ding","year":"2020","unstructured":"Ding J, Su S, You T, Xia T, Lin X, Chen Z, et al. Serum interleukin-6 level is correlated with the disease activity of systemic lupus erythematosus: a meta-analysis. Clin (Sao Paulo). 2020;75:e1801.","journal-title":"Clin (Sao Paulo)"},{"issue":"2","key":"3653_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cyto.2015.05.007","volume":"76","author":"SM Abdel Galil","year":"2015","unstructured":"Abdel Galil SM, Ezzeldin N, El-Boshy ME. The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis. Cytokine. 2015;76(2):280\u20137.","journal-title":"Cytokine"},{"key":"3653_CR22","doi-asserted-by":"publisher","first-page":"155841","DOI":"10.1016\/j.cyto.2022.155841","volume":"153","author":"S Wu","year":"2022","unstructured":"Wu S, Zhang Y, Ma J, Liu Y, Li W, Wang T, et al. Interleukin-6 absence triggers intestinal microbiota dysbiosis and mucosal immunity in mice. Cytokine. 2022;153:155841.","journal-title":"Cytokine"},{"issue":"3","key":"3653_CR23","doi-asserted-by":"publisher","first-page":"e85345","DOI":"10.1371\/journal.pone.0085345","volume":"9","author":"R Al-Sadi","year":"2014","unstructured":"Al-Sadi R, Ye D, Boivin M, Guo S, Hashimi M, Ereifej L, et al. Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene. PLoS ONE. 2014;9(3):e85345.","journal-title":"PLoS ONE"},{"key":"3653_CR24","doi-asserted-by":"crossref","unstructured":"Mohd R, Chin SF, Shaharir SS, Cham QS. Involvement of gut microbiota in SLE and lupus nephritis. Biomedicines. 2023;11(3).","DOI":"10.3390\/biomedicines11030653"},{"key":"3653_CR25","doi-asserted-by":"publisher","first-page":"645500","DOI":"10.3389\/fmicb.2021.645500","volume":"12","author":"B Zhao","year":"2021","unstructured":"Zhao B, Zhou B, Dong C, Zhang R, Xie D, Tian Y, et al. Lactobacillus reuteri alleviates Gastrointestinal toxicity of rituximab by regulating the Proinflammatory T cells in vivo. Front Microbiol. 2021;12:645500.","journal-title":"Front Microbiol"},{"key":"3653_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-immunol-042617-053238","volume":"36","author":"AJ Macpherson","year":"2018","unstructured":"Macpherson AJ, Yilmaz B, Limenitakis JP, Ganal-Vonarburg SC. IgA function in relation to the intestinal microbiota. Annu Rev Immunol. 2018;36:359\u201381.","journal-title":"Annu Rev Immunol"},{"key":"3653_CR27","doi-asserted-by":"publisher","first-page":"1080154","DOI":"10.3389\/fimmu.2023.1080154","volume":"14","author":"S Romero-Ramirez","year":"2023","unstructured":"Romero-Ramirez S, Sosa-Hernandez VA, Cervantes-Diaz R, Carrillo-Vazquez DA, Meza-Sanchez DE, Nunez-Alvarez C, et al. Salivary IgA subtypes as novel disease biomarkers in systemic lupus erythematosus. Front Immunol. 2023;14:1080154.","journal-title":"Front Immunol"},{"issue":"1","key":"3653_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12967-018-1723-0","volume":"16","author":"R Lin","year":"2018","unstructured":"Lin R, Chen H, Shu W, Sun M, Fang L, Shi Y, et al. Clinical significance of soluble Immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease. J Transl Med. 2018;16(1):359.","journal-title":"J Transl Med"},{"issue":"1","key":"3653_CR29","doi-asserted-by":"publisher","first-page":"16672","DOI":"10.1038\/s41598-021-96289-5","volume":"11","author":"Y Masu","year":"2021","unstructured":"Masu Y, Kanazawa Y, Kakuta Y, Shimoyama Y, Onodera M, Naito T, et al. Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease. Sci Rep. 2021;11(1):16672.","journal-title":"Sci Rep"},{"key":"3653_CR30","doi-asserted-by":"publisher","first-page":"109107","DOI":"10.1016\/j.clim.2022.109107","volume":"242","author":"R Gudi","year":"2022","unstructured":"Gudi R, Kamen D, Vasu C. Fecal Immunoglobulin A (IgA) and its subclasses in systemic lupus erythematosus patients are nuclear antigen reactive and this feature correlates with gut permeability marker levels. Clin Immunol. 2022;242:109107.","journal-title":"Clin Immunol"},{"issue":"1","key":"3653_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13023-021-02044-4","volume":"16","author":"L Chen","year":"2021","unstructured":"Chen L, He Q, Luo M, Gou Y, Jiang D, Zheng X, et al. Clinical features of lupus enteritis: a single-center retrospective study. Orphanet J Rare Dis. 2021;16(1):396.","journal-title":"Orphanet J Rare Dis"},{"key":"3653_CR32","doi-asserted-by":"publisher","first-page":"100106","DOI":"10.1016\/j.jtauto.2021.100106","volume":"4","author":"RB Frittoli","year":"2021","unstructured":"Frittoli RB, Vivaldo JF, Costallat LTL, Appenzeller S. Gastrointestinal involvement in systemic lupus erythematosus: A systematic review. J Transl Autoimmun. 2021;4:100106.","journal-title":"J Transl Autoimmun"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03653-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:23:46Z","timestamp":1759173826000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03653-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3653"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03653-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6442760\/v1","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (2013 revision) and received approval from the Medical Ethics Committee of Shanxi Bethune Hospital (Approval No. YXLL-2022-115).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients and\/or the public were not involved in the design, conduct, reporting, or dissemination plans of this research. Patient consent for publication is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}